leon ptaszek
Massachusetts General Hospital, Harvard Medical School
Boston, United States
Associate Editor
Cardiovascular and Hematologic Drugs
- Frontiers in Drug Discovery
- Cardiovascular and Hematologic Drugs
- Editorial Board
Type at least 3 characters
73 editors
Shape the future of research in your field
Join the board
Editors
Associate Editors
lakshmi pulakat
Tufts Medical Center
Boston, United States
Associate Editor
Cardiovascular and Hematologic Drugs
gautam ramani
University of Maryland
Baltimore, United States
Associate Editor
Cardiovascular and Hematologic Drugs
mark j. ranek
Johns Hopkins University
Baltimore, United States
Associate Editor
Cardiovascular and Hematologic Drugs
monica shah
IQVIA (United States)
Plymouth Meeting, United States
Associate Editor
Cardiovascular and Hematologic Drugs
xin wang
The University of Manchester
Manchester, United Kingdom
Associate Editor
Cardiovascular and Hematologic Drugs
young-sup yoon
Emory University
Atlanta, United States
Associate Editor
Cardiovascular and Hematologic Drugs
Review Editors
marina anastasiou
Independent researcher
Athens, Greece
Review Editor
Cardiovascular and Hematologic Drugs
xiaoping bao
Purdue University
West Lafayette, United States
Review Editor
Cardiovascular and Hematologic Drugs
jason becker
School of Medicine, University of Pittsburgh
Pittsburgh, United States
Review Editor
Cardiovascular and Hematologic Drugs
robert morris blanton
Tufts Medical Center
Boston, United States
Review Editor
Cardiovascular and Hematologic Drugs
han chen
Department of Cardiology, Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, China
Review Editor
Cardiovascular and Hematologic Drugs
howard h chen
Tufts Medical Center
Boston, United States
Review Editor
Cardiovascular and Hematologic Drugs
young wook chun
University of Maryland
Baltimore, United States
Review Editor
Cardiovascular and Hematologic Drugs
william chutkow
Novartis Institutes for BioMedical Research
Cambridge, United States
Review Editor
Cardiovascular and Hematologic Drugs
alicia de la cruz
Sols-Morreale Biomedical Research Institute (IIBM), Faculty of Medicine, Autonomous University of Madrid
Madrid, Spain
Review Editor
Cardiovascular and Hematologic Drugs